Clinical Trials Directory

Trials / Completed

CompletedNCT03735017

Virtual Reality Walking for Neuropathic Pain in Spinal Cord Injury

Immersive Virtual Walking Treatment for Neuropathic Pain in Spinal Cord Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

This study will examine the effectiveness of one of two virtual reality treatments on neuropathic pain in individuals with spinal cord injury.

Detailed description

The investigators are investigating the effectiveness of one of two possible investigational virtual reality treatments on neuropathic pain in individuals with spinal cord injury. Participants will be randomized to one of these two treatments.

Conditions

Interventions

TypeNameDescription
OTHERNon-Interactive Virtual Reality WalkingIndividuals will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.
OTHERInteractive Virtual Reality WalkingIndividuals will wear a head-mounted display to allow them to visualize virtual legs in the virtual environment. When wearing the display, individuals will see the legs and arms of their virtual avatar from a first-person perspective. Individuals will engage in virtual reality sessions in their home twice daily over the course of 10 days in a two-week period. Each daily session will take approximately 30 minutes, with 5-10 minutes dedicated to the virtual walking experience. Additionally, each daily session will be scheduled a minimum of 4 hours apart.

Timeline

Start date
2018-06-16
Primary completion
2019-07-30
Completion
2019-07-30
First posted
2018-11-08
Last updated
2021-11-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03735017. Inclusion in this directory is not an endorsement.